Inside Sales Account Manager based in the United States (MN, IL, WI)
In this role, you’ll grow revenue across an assigned territory by qualifying and converting new opportunities, deepening relationships with existing customers, and partnering closely with Marketing, Field Sales, and Channel teams.
What you’ll do
- Own inbound leads from first touch to close: qualify, scope needs, build business cases, and drive conversion.
- Increase product usage per user and expand within accounts through consultative outreach and upsell/cross-sell motions.
- Deliver timely product updates and technical information to new and existing customers.
- Run campaigns in partnership with Marketing; execute targeted call/email sequences and webinars.
- Maintain rigorous CRM hygiene: track pipeline, forecast accurately, and capture competitive/commercial intelligence.
- Support field reps with account research, meeting prep/follow-up, quotes, and trial coordination across active territories.
- Champion retention by building strong relationships and ensuring a smooth customer experience post-sale.
What you’ll bring
Required
- BSc and/or Master’s degree (preferably in Life Sciences, Genetics, or Genomics).
- Proven inside sales or commercial experience serving research/life-science customers.
- Working understanding of DNA sequencing technologies and applications.
- Proficiency with CRM systems (e.g., Salesforce, HubSpot) and data-driven selling.
- Excellent communication, influence, and teamwork skills; thrive in a fast-paced, goal-oriented environment.
- Positive, proactive, can-do mindset with sound judgment and tact.
Nice to have
- PhD (advantageous but not required).
- Experience operating in global teams and coordinating with field-based colleagues and channel partners.
- Familiarity with complex, multi-stakeholder sales cycles in academia, biotech, pharma, clinical, or government labs.
The salary for this role is between $66,000 and $83,000 USD. The salary offered will reflect the skills and experience of the candidate.
Certain roles within ONT are eligible for annual bonus and stock. These awards are allocated based on individual performance.
Employees based in the US have the option to choose healthcare benefits, participate in the company 401(k) plan and company match, we also offer short-term and long-term disability coverage, basic life insurance, and commuter benefits to name a few.
We are proud to be an equal opportunity employer. We select and employ candidates only in accordance with their merits, qualifications, and abilities to perform the duties of the job regardless of gender, marital status, race, religion, color, age, disability, sexual orientation, military or veteran status. If you require an accommodation to complete the application or interview process, please contact [email protected]
#LI-Remote
#LI-RS1
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Similar Jobs
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
